Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients
Clinical trial NCT03381118 · TERMINATED
Trial details
- NCT number
- NCT03381118
- Sponsor
- St. Petersburg State Pavlov Medical University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2018-09-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.